No analysts, no underwriters. The last two financings have been non-brokered private placements.
The last financing that was underwriter was the convertible debentures announced in June 2023.
It was done by Research Capital on a "best efforts" basis.
The company had hoped to raise $5 million.
They raised $3,030,000.
Pascali bought $2 million of that.
This company will never find an underwriter again.
They seem very reluctant to file a prospectus.
No analyst coverage, and no underwriter.
That's just plain grim.